Focusing on rarer cancers in Europe

May 8, 2017

For more information on this new initiative, please click here EURACAN.

 

Recent News

New Research Trial – The NELMAS trial

NELMAS - An international multi-centre, stratified, open, randomized, comparator-controlled, parallel-group phase II study comparing adjuvant treatment with 177Lu-DOTATATE (Lutathera®) to best supportive care in patients after resection of neuroendocrine liver...

read more